A Win For Alterity Therapeutics Limited
Mon, Mar 23, 2020 at 05:30 PM
Alterity Therapeutics Limited (ATHE:NASDAQ) rocketted at $0.72, a gain of 103.6%. On Fri 20 Mar 20, ATHE:NASDAQ hit a New 2-Week Intraday Low of $0.28. From Fri 06 Mar 20, the stock recorded 20.00% Up Days and 27.27% Green Days
About Alterity Therapeutics Limited (ATHE:NASDAQ)
Prana Biotechnology Ltd is active in the healthcare domain. The company is engaged in research collaboration with Takeda for the treatment of Parkinson's disease gastrointestinal neuropathology. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (PBT434) and brain cancer (PBT519), which are in pre-clinical toxicology testing.
Top 10 Gainers:
- Alterity Therapeutics Limited (ATHE:NASDAQ), 103.56%
- Daseke, Inc. (DSKE:NASDAQ), 67.95%
- Ritter Pharmaceuticals, Inc. (RTTR:NASDAQ), 61.51%
- ALJ Regional Holdings, Inc. (ALJJ:NASDAQ), 57.02%
- Jiayin Group Inc. (JFIN:NASDAQ), 55.38%
- Indonesia Energy Corporation Limited (INDO:NYSEMKT), 47.35%
- Wilhelmina International, Inc. (WHLM:NASDAQ), 44.44%
- LMP Automotive Holdings, Inc. (LMPX:NASDAQ), 42.04%
- 8i Enterprises Acquisition Corp. (JFK:NASDAQ), 40.79%
- Century Casinos, Inc. (CNTY:NASDAQ), 39.13%